ArticleOphthalmology and therapy2025

Real-World Outcomes of Allogeneic Immunosafe Plasma Rich in Growth Factors Eye Drops for Refractory Ocular Surface Diseases: A Prospective Observational Study.

Rosa Alvarado-Villacorta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.